|
|
Exchange: |
Nasdaq National Market |
Security
Type: |
Common |
Shares
Out: |
11,450,000 |
Market
Cap: |
8.59(M) |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$0.2893 - $1.35 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Monopar Therapeutics is a biopharmaceutical company focused on developing proprietary therapeutics for cancer patients. Co.'s compounds in development: Validive®, a Phase 2b/3 clinical stage, mucoadhesive buccal tablet for the prevention of radiation induced severe oral mucositis in oropharyngeal cancer patients; camsirubicin, a Phase 1b clinical stage analog of doxorubicin engineered specifically to retain anticancer activity while minimizing toxic effects on the heart; MNPR-101, a preclinical stage uPAR-targeted antibody being developed as a radioimmunotherapeutic and companion diagnostic for cancers and COVID-19; and an early stage camsirubicin analog, MNPR-202, for various cancers.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
16,053 |
Total Buy Value |
$0 |
$0 |
$0 |
$49,659 |
Total People Bought |
0 |
0 |
0 |
1 |
Total Buy Transactions |
0 |
0 |
0 |
2 |
Total Shares Sold |
0 |
0 |
0 |
0 |
Total Sell Value |
$0 |
$0 |
$0 |
$0 |
Total People Sold |
0 |
0 |
0 |
0 |
Total Sell Transactions |
0 |
0 |
0 |
0 |
End Date |
2024-02-08 |
2023-11-07 |
2023-05-09 |
2022-05-09 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Cittadine Andrew |
Chief Operating Officer |
|
2022-12-31 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,062 |
28,300 |
|
- |
|
Tsuchimoto Kim R |
Chief Financial Officer |
|
2022-12-31 |
4 |
D |
$2.37 |
$4,899 |
D/D |
(2,067) |
17,779 |
|
- |
|
Tsuchimoto Kim R |
Chief Financial Officer |
|
2022-12-31 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,067 |
19,846 |
|
- |
|
Starr Christopher M |
Director |
|
2022-12-31 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,859 |
15,730 |
|
- |
|
Cittadine Andrew |
Chief Operating Officer |
|
2022-11-15 |
4 |
B |
$3.15 |
$31,500 |
D/D |
10,000 |
24,238 |
2.74 |
-47% |
|
Cittadine Andrew |
Chief Operating Officer |
|
2022-11-14 |
4 |
B |
$3.00 |
$18,159 |
D/D |
6,053 |
14,238 |
2.74 |
-53% |
|
Cittadine Andrew |
Chief Operating Officer |
|
2022-09-30 |
4 |
D |
$1.52 |
$1,810 |
D/D |
(1,191) |
8,185 |
|
- |
|
Cittadine Andrew |
Chief Operating Officer |
|
2022-09-30 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,063 |
9,376 |
|
- |
|
Klausner Arthur J |
|
|
2022-09-30 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,859 |
17,871 |
|
- |
|
Tsuchimoto Kim R |
Chief Financial Officer |
|
2022-09-30 |
4 |
D |
$1.52 |
$2,665 |
D/D |
(1,753) |
14,779 |
|
- |
|
Tsuchimoto Kim R |
Chief Financial Officer |
|
2022-09-30 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,066 |
16,532 |
|
- |
|
Robinson Chandler |
Chief Executive Officer |
|
2022-09-30 |
4 |
D |
$1.52 |
$6,197 |
D/D |
(4,077) |
63,236 |
|
- |
|
Robinson Chandler |
Chief Executive Officer |
|
2022-09-30 |
4 |
OE |
$0.00 |
$0 |
D/D |
13,911 |
67,313 |
|
- |
|
Brown Michael J |
|
|
2022-09-30 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,859 |
222,871 |
|
- |
|
Starr Christopher M |
|
|
2022-09-30 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,859 |
12,871 |
|
- |
|
Anderson Raymond |
|
|
2022-09-30 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,859 |
13,871 |
|
- |
|
Klausner Arthur J |
|
|
2022-06-30 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,859 |
15,012 |
|
- |
|
Anderson Raymond |
|
|
2022-06-30 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,859 |
11,012 |
|
- |
|
Tsuchimoto Kim R |
Chief Financial Officer |
|
2022-06-30 |
4 |
D |
$2.30 |
$7,088 |
D/D |
(3,083) |
11,466 |
|
- |
|
Tsuchimoto Kim R |
Chief Financial Officer |
|
2022-06-30 |
4 |
OE |
$0.00 |
$0 |
D/D |
8,913 |
14,549 |
|
- |
|
Cittadine Andrew |
Chief Operating Officer |
|
2022-06-30 |
4 |
D |
$2.30 |
$6,465 |
D/D |
(2,812) |
5,313 |
|
- |
|
Cittadine Andrew |
Chief Operating Officer |
|
2022-06-30 |
4 |
OE |
$0.00 |
$0 |
D/D |
8,125 |
8,125 |
|
- |
|
Robinson Chandler |
Chief Executive Officer |
|
2022-06-30 |
4 |
D |
$2.30 |
$16,091 |
D/D |
(6,999) |
53,402 |
|
- |
|
Robinson Chandler |
Chief Executive Officer |
|
2022-06-30 |
4 |
OE |
$0.00 |
$0 |
D/D |
23,882 |
60,401 |
|
- |
|
Brown Michael J |
|
|
2022-06-30 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,859 |
220,012 |
|
- |
|
155 Records found
|
|
Page 3 of 7 |
|
|